NASDAQ:PRCT PROCEPT BioRobotics Q2 2026 Earnings Report $19.32 +0.10 (+0.54%) As of 02:51 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast PROCEPT BioRobotics EPS ResultsActual EPSN/AConsensus EPS -$0.46Beat/MissN/AOne Year Ago EPSN/APROCEPT BioRobotics Revenue ResultsActual RevenueN/AExpected Revenue$92.64 millionBeat/MissN/AYoY Revenue GrowthN/APROCEPT BioRobotics Announcement DetailsQuarterQ2 2026Date8/4/2026TimeAfter Market ClosesConference Call DateTuesday, August 4, 2026Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile PROCEPT BioRobotics Earnings HeadlinesPROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026July 14, 2026 | globenewswire.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Rating of "Hold" from AnalystsJuly 12, 2026 | americanbankingnews.comSMX: From Under-the-Radar to Must-Watch!SMX (Security Matters) PLC is building Digital Material Passport technology that embeds molecular-level markers directly into plastics, metals, fuels, and textiles - giving every material a secure, verifiable digital identity. With commodity prices climbing, recycled materials turning cost-competitive, and governments cracking down on fraud and mislabeling, the demand for material verification infrastructure is growing fast. SMX bridges the gap between physical assets and digital compliance.July 20 at 1:00 AM | Smallcaps Daily (Ad)Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)July 10, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)July 6, 2026 | theglobeandmail.comEvercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth PotentialJune 29, 2026 | insidermonkey.comSee More PROCEPT BioRobotics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PROCEPT BioRobotics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PROCEPT BioRobotics and other key companies, straight to your email. Email Address About PROCEPT BioRoboticsPROCEPT BioRobotics (NASDAQ:PRCT), Inc. is a medical device company specializing in the development and commercialization of robotic systems for the treatment of benign prostatic hyperplasia (BPH). The company’s technology leverages precision robotics and real-time imaging to perform minimally invasive procedures, aiming to reduce patient recovery time and improve clinical outcomes compared to traditional surgical approaches. The company’s flagship product, the AquaBeam Robotic System, uses a high-velocity waterjet to selectively remove prostate tissue while preserving surrounding healthy structures. The system is designed for use in an outpatient setting, offering physicians a controlled robotic platform to carry out targeted tissue resection without the need for thermal energy. This approach is intended to minimize complications such as urinary incontinence and sexual dysfunction often associated with conventional BPH treatments. Headquartered in Redwood City, California, PROCEPT BioRobotics was founded in 2008 by Serdar Bozkurt, MD, who continues to serve as Chief Medical Officer. The AquaBeam Robotic System received U.S. Food and Drug Administration (FDA) clearance in 2016 and a CE mark for European markets, positioning the company to serve healthcare providers across North America and select international territories. PROCEPT has built a network of clinical partners and distributors to support physician training and system installation. With a focus on advancing urological care through innovation, PROCEPT BioRobotics invests in ongoing research and development to expand its platform’s capabilities and explore new indications. The company maintains collaborations with leading academic institutions and surgical centers to refine procedural protocols and gather long-term clinical data, underscoring its commitment to evidence-based adoption of robotic waterjet ablation technology.View PROCEPT BioRobotics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Is Domino's Stock Serving Up a Buying Opportunity?Meta Platforms Turns AI Power Scarcity Into a $10 Billion Cloud BetAmazon’s AI Spending Is About to Face Its Most Important AWS Test YetMarketBeat Week in Review – 07/13- 07/17Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to BenefitBank Earnings Are Roaring, But Wall Street Isn't Ready to CelebrateThe Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Upcoming Earnings General Motors (7/21/2026)Northrop Grumman (7/21/2026)America Movil (7/21/2026)Alphabet (7/21/2026)Chubb (7/21/2026)Capital One Financial (7/21/2026)Interactive Brokers Group (7/21/2026)Charles Schwab (7/21/2026)Danaher (7/21/2026)Novartis (7/21/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
